Sanofi India Limited (SANOFI)
Healthcare | Drug Manufacturers - General
₹6207.0
0.38% (₹23.5)
Market Overview
| Market Cap | 143201697792 |
| Volume | 8891 |
| 52W High | ₹10524.95 |
| 52W Low | ₹4902.0 |
Key Ratios
| P/E Ratio | 45.62629 |
| EPS | 136.04 |
| Beta | 0.215 |
| Dividend Yield | 1.89% |
Financial Performance
Revenue Growth
-0.258%
Profit Margin
0.2053%
ROE
0.33446997%
ROA
0.17063%
Stock Analysis Score: 60/100
Growth Score: 60/100
Key Strengths:
- Excellent profit margins above 15%
- Strong ROE above 15%
- Low volatility with beta below 1
- Strong operating margins above 15%
Recommendation
Buy - The stock shows good fundamentals with some room for improvement
Detailed Analysis
Growth: -0.3% revenue growth indicates weak business expansion.
Profitability: 20.5% profit margin shows excellent operational efficiency.
Returns: ROE of 33.4% demonstrates strong return on shareholder investment.
Valuation: PE ratio of 45.6x is expensive compared to market averages.
Trading Decision Guide
- Score 80-100: Consider for long-term investment with high conviction
- Score 60-79: Suitable for medium-term investment with regular monitoring
- Score 40-59: Short-term trading opportunities, maintain strict stop-losses
- Score Below 40: High-risk trading only, thorough research essential
Risk Factors
- Market Cap: ₹14320.2Cr
- Beta: 0.21 (Market Volatility)
- 52-Week Range: ₹4902.0 - ₹10525.0
Last Updated: 2025-04-16 19:46:21